Latest news and blogs
The public hearing was part of a safety review by the EMA into the use of sodium valproate in women who are pregnant or of childbearing age.
Lacosamide epilepsy medicine approved for use in children over 4 years old with focal-onset seizures
The lacosamide medicine was approved in September for use on its own or alongside other medicines to treat focal-onset seizures. It was previously approved for use in teenagers over 16 years old and adults in Europe.
Almost one-fifth of women taking sodium valproate for epilepsy still not aware of risks in pregnancy, survey shows
More than a quarter (28%) of the women currently taking sodium valproate said in the survey that they had not been informed of the risks of this medicine in pregnancy.